Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Akron › NPI 1861506560
Hospital

Children's Hospital Medical Center of Akron

Children's Hospital Medical Center of Akron was paid $556.65M by Medicaid between Jan 2018 and Dec 2024, across 717 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 26% of everything it billed.

33Billing provider infoCHILDREN'S HOSPITAL MEDICAL CENTER OF AKRON
AKRON, OH 44308
33aNPI1861506560assigned 08/18/2006
33bProvider typeChildren's Hospital
28Total paid$556.65M
24GClaims6,634,271
24DCodes billed717
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Children's Hospital providers in Ohio

Rank by total paid#1 of 7
Median peer was paid$12.53M
This provider vs. median44×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10M$20M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018627,653$40.13M
2019706,416$43.44M
2020598,283$55.74M
2021670,508$65.08M
2022726,281$67.62M
20231,880,867$147.39M
2024incomplete1,424,263$137.25M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 26% 991,232 879,763 $146.97M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 10% 349,258 315,856 $56.74M
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 5.4% 217,031 203,330 $30.19M
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 5.2% 215,592 198,126 $28.95M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 4.9% 162,047 149,259 $27.52M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 4.4% 160,882 150,111 $24.35M
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 3.0% 121,188 112,823 $16.64M
92551 2.3% 142,134 131,235 $12.96M
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia 1.9% 5,730 4,894 $10.64M
99215 Doctor's office visit, returning patient (complex)Prolong outpt/office vis 1.8% 61,517 54,598 $10.11M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 1.7% 47,882 41,258 $9.43M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1.5% 60,486 53,894 $8.57M
705 more codes
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 1.3% 53,877 $7.43M
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.1% 58,158 $6.13M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 44,510 $5.54M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 21,560 $5.33M
90834 Psychotherapy session, about 45 minutes <1% 26,009 $5.23M
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 3,361 $5.20M
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 33,441 $4.84M
96361 Intravenous infusion, hydration; each additional hour <1% 8,598 $4.80M
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 22,080 $3.90M
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 33,594 $3.69M
D2930 Prefabricated stainless steel crown - primary tooth <1% 4,889 $3.63M
J0585 Injection, onabotulinumtoxina, 1 unit <1% 1,621 $2.92M
G0378 Hospital observation service, per hour <1% 28,158 $2.82M
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 19,297 $2.82M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 5,994 $2.63M
67311 <1% 808 $2.55M
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 335,448 $2.52M
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 14,065 $2.52M
D7140 Extraction, erupted tooth or exposed root <1% 4,463 $2.45M
76770 <1% 9,722 $2.45M
70450 Computed tomography, head or brain; without contrast material <1% 3,572 $1.84M
76819 Fetal biophysical profile; without non-stress testing <1% 12,762 $1.81M
93325 <1% 13,329 $1.79M
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 4,858 $1.79M
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 6,078 $1.77M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 2,584 $1.77M
90839 <1% 8,979 $1.75M
42830 <1% 1,253 $1.70M
90899 <1% 12,528 $1.69M
95812 <1% 1,239 $1.63M
90791 Psychiatric diagnostic evaluation <1% 4,939 $1.59M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 5,595 $1.53M
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study <1% 3,375 $1.51M
97803 <1% 11,833 $1.37M
90686 <1% 145,580 $1.36M
92567 <1% 29,352 $1.14M
95004 Percutaneous tests with allergenic extracts, immediate type reaction <1% 10,049 $1.12M
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 1,010 $1.10M
54150 <1% 665 $1.06M
D3220 Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction <1% 2,017 $1.06M
93304 <1% 2,140 $1.05M
90670 <1% 102,394 $1.01M
Q5103 Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg <1% 1,432 $969K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 5,664 $965K
A0427 Emergency ambulance ride, advanced life support <1% 5,512 $936K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 10,092 $928K
95716 <1% 713 $920K
A0425 Ground mileage, per statute mile <1% 10,810 $867K
90847 Family psychotherapy with the patient present, 50 minutes <1% 3,281 $855K
J1745 Injection, infliximab, excludes biosimilar, 10 mg <1% 615 $839K
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg <1% 488 $777K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 7,222 $769K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 11,338 $758K
90832 Psychotherapy session, about 30 minutes <1% 4,878 $732K
A0434 Specialty care transport (sct) <1% 3,749 $727K
95715 <1% 539 $726K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 14,850 $710K
90837 Psychotherapy session, about an hour <1% 3,472 $695K
70551 Magnetic resonance imaging, brain; without contrast material <1% 1,950 $688K
41899 Unlisted procedure, dentoalveolar structures <1% 1,231 $679K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 836 $671K
83655 <1% 60,156 $657K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 144,426 $655K
92523 <1% 5,644 $638K
D1351 Sealant - per tooth <1% 1,080 $636K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 5,404 $611K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 3,825 $602K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 1,290 $585K
95782 <1% 521 $580K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 2,416 $567K
01922 <1% 1,873 $559K
96415 <1% 1,035 $557K
95117 <1% 12,823 $556K
64643 <1% 886 $554K
94762 <1% 7,527 $552K
44970 <1% 181 $533K
80053 Comprehensive metabolic panel <1% 37,285 $530K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 2,740 $523K
29075 <1% 2,651 $510K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 1,136 $484K
97802 <1% 4,123 $482K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,266 $478K
81229 <1% 638 $478K
90633 <1% 49,274 $475K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 36,588 $469K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 5,732 $456K
92588 <1% 3,166 $448K
97162 <1% 3,998 $447K
41010 <1% 347 $442K
17110 <1% 1,865 $433K
92555 <1% 11,172 $432K
D2330 <1% 723 $430K
76801 <1% 1,997 $428K
16020 <1% 3,595 $424K
97161 <1% 3,645 $394K
95700 <1% 1,773 $391K
94010 <1% 10,193 $391K
96127 <1% 5,457 $391K
90698 <1% 50,852 $377K
92526 <1% 3,737 $376K
D2391 Resin-based composite - one surface, posterior, primary or permanent <1% 909 $373K
97166 <1% 2,372 $371K
90697 <1% 35,471 $366K
74230 <1% 1,504 $358K
D2392 Resin-based composite - two surfaces, posterior, primary or permanent <1% 1,082 $346K
92579 <1% 2,579 $338K
96156 <1% 1,008 $334K
97116 <1% 4,289 $328K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,278 $320K
76000 <1% 2,037 $316K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 1,127 $312K
54161 <1% 202 $311K
96161 <1% 4,587 $307K
A0431 Ambulance service, conventional air services, transport, one way (rotary wing) <1% 170 $303K
96158 <1% 2,699 $302K
D1510 <1% 466 $299K
90680 <1% 59,557 $294K
90472 Immunization administration, each additional vaccine (list separately) <1% 186,166 $290K
84443 Thyroid stimulating hormone (TSH) <1% 22,548 $290K
70491 <1% 607 $286K
93308 <1% 530 $280K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 62,385 $275K
93975 <1% 1,764 $272K
76825 <1% 1,672 $269K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 61,629 $268K
D2740 Crown - porcelain/ceramic <1% 285 $265K
74018 <1% 8,475 $261K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 728 $260K
12011 <1% 1,000 $246K
93976 <1% 974 $241K
76820 <1% 2,532 $238K
71046 Radiologic examination, chest; 2 views <1% 24,485 $232K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 30,236 $223K
12001 <1% 875 $216K
92587 <1% 1,745 $216K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 17,147 $213K
93226 <1% 1,243 $210K
76857 <1% 1,441 $209K
49452 <1% 586 $205K
29425 <1% 1,044 $205K
D2390 <1% 337 $205K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 21,223 $200K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 15,575 $200K
36415 Collection of venous blood by venipuncture <1% 92,642 $199K
97167 <1% 1,123 $185K
74240 <1% 828 $185K
84439 <1% 10,787 $184K
76536 <1% 1,175 $173K
90744 <1% 21,814 $173K
29065 <1% 869 $173K
70486 <1% 866 $170K
80061 Lipid panel <1% 15,028 $169K
92611 <1% 1,485 $167K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 1,124 $166K
86140 <1% 22,157 $164K
11900 <1% 647 $164K
90651 <1% 17,980 $163K
96160 <1% 4,506 $160K
97168 <1% 1,050 $160K
97164 <1% 1,359 $160K
76827 <1% 1,665 $159K
97760 <1% 1,399 $157K
97165 <1% 1,044 $157K
92508 Group treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 1,242 $151K
92250 <1% 2,565 $149K
92652 <1% 1,203 $148K
83036 Hemoglobin; glycosylated (A1C) <1% 26,286 $143K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 4,843 $142K
90619 <1% 14,138 $142K
96132 <1% 568 $139K
D2393 Resin-based composite - three surfaces, posterior, primary or permanent <1% 452 $137K
70360 <1% 2,850 $137K
90677 <1% 14,908 $136K
80048 Basic metabolic panel (calcium, ionized) <1% 13,819 $134K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 9,276 $133K
90480 <1% 4,825 $131K
96130 <1% 528 $127K
82728 <1% 9,564 $127K
76885 <1% 807 $126K
96116 <1% 403 $126K
96138 <1% 658 $122K
12051 <1% 457 $121K
83516 <1% 6,714 $121K
92557 <1% 943 $118K
87507 <1% 938 $116K
95819 <1% 402 $111K
95811 <1% 90 $110K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 655 $109K
76800 <1% 632 $109K
10060 <1% 411 $107K
92610 <1% 1,490 $106K
90620 <1% 5,396 $106K
76882 <1% 881 $104K
74019 <1% 12,133 $102K
90696 <1% 12,509 $102K
29085 <1% 522 $101K
95076 <1% 243 $101K
99442 <1% 542 $97K
80069 <1% 4,833 $92K
C9285 Lidocaine 70 mg/tetracaine 70 mg, per patch <1% 1,548 $91K
24538 <1% 13 $90K
82784 <1% 7,316 $89K
90715 <1% 10,230 $89K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 558 $89K
42821 <1% 41 $88K
87086 Culture, bacterial; quantitative colony count, urine <1% 24,740 $87K
36000 <1% 1,202 $86K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 9,275 $85K
00170 Anesthesia for intraoral procedures, including biopsy <1% 18,858 $84K
90785 <1% 1,325 $83K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient <1% 1,048 $82K
95951 <1% 127 $82K
49591 <1% 36 $81K
51784 <1% 213 $81K
76813 <1% 656 $80K
90648 <1% 9,834 $79K
90716 <1% 12,110 $78K
92556 <1% 1,182 $77K
87081 <1% 31,932 $74K
90685 <1% 8,556 $74K
90710 <1% 14,481 $72K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 8,013 $71K
76937 <1% 1,156 $68K
85027 <1% 14,298 $67K
64642 <1% 851 $67K
0071A <1% 1,880 $66K
97113 <1% 519 $65K
90700 <1% 12,096 $64K
90707 <1% 12,036 $64K
80076 <1% 6,047 $63K
0154A <1% 1,599 $62K
A0426 Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) <1% 339 $61K
77072 <1% 1,488 $60K
72081 <1% 1,286 $59K
94060 <1% 469 $59K
96367 <1% 546 $59K
A0436 Rotary wing air mileage, per statute mile <1% 168 $58K
0124A <1% 1,569 $57K
A0428 Ambulance service, basic life support, non-emergency transport, (bls) <1% 365 $55K
G0168 Wound closure utilizing tissue adhesive(s) only <1% 207 $54K
83540 <1% 6,734 $54K
93225 <1% 1,052 $54K
96139 <1% 656 $54K
77075 <1% 300 $53K
97750 <1% 610 $52K
90846 Family psychotherapy without the patient present, 50 minutes <1% 247 $52K
81001 <1% 31,631 $50K
0081A <1% 1,636 $49K
76506 <1% 303 $49K
54163 <1% 31 $48K
97535 Self-care/home management training, each 15 minutes <1% 833 $46K
86003 <1% 4,581 $46K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 55,513 $45K
83550 <1% 6,670 $43K
86850 <1% 1,346 $42K
95115 <1% 903 $41K
0072A <1% 1,183 $41K
69610 <1% 35 $39K
92552 <1% 1,410 $39K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 427 $38K
87077 <1% 9,276 $37K
83520 <1% 2,243 $37K
90656 <1% 3,908 $37K
73610 <1% 4,685 $35K
81002 <1% 33,880 $34K
72141 <1% 162 $34K
97014 <1% 721 $34K
90474 <1% 45,233 $33K
96111 <1% 141 $33K
73630 <1% 4,382 $33K
81243 <1% 177 $32K
11102 <1% 40 $32K
73521 <1% 1,533 $32K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 64 $31K
97763 <1% 315 $30K
72197 <1% 51 $29K
0082A <1% 863 $29K
87493 <1% 631 $28K
73562 <1% 2,524 $28K
99443 <1% 152 $27K
73140 <1% 3,998 $27K
86880 <1% 1,546 $27K
84460 <1% 5,639 $26K
91320 <1% 1,040 $26K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 27,098 $26K
0001A <1% 957 $26K
85652 <1% 6,390 $26K
J3590 Unclassified biologics <1% 35 $25K
86900 <1% 1,556 $25K
76870 <1% 965 $25K
80197 <1% 1,169 $24K
73110 <1% 3,644 $24K
D2331 <1% 60 $24K
99156 <1% 331 $24K
97150 Therapeutic procedure(s), group (2 or more individuals) <1% 201 $23K
99441 <1% 135 $23K
81025 <1% 19,133 $23K
85610 <1% 3,413 $23K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 26,964 $23K
00120 <1% 473 $23K
86665 <1% 2,010 $23K
82947 <1% 2,939 $22K
29405 <1% 115 $22K
73130 <1% 3,738 $22K
74455 <1% 145 $22K
85018 <1% 41,216 $22K
82977 <1% 2,233 $21K
83970 <1% 954 $21K
92545 <1% 184 $20K
92582 <1% 298 $20K
20680 <1% 15 $20K
91319 <1% 1,397 $20K
83993 <1% 826 $20K
00400 <1% 782 $20K
92133 <1% 357 $20K
0002A <1% 722 $20K
83735 <1% 3,569 $20K
86592 <1% 1,239 $20K
72082 <1% 756 $19K
73090 <1% 2,739 $19K
83001 <1% 1,495 $18K
96152 <1% 150 $18K
73590 <1% 2,076 $18K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient <1% 546 $18K
92607 <1% 254 $18K
82533 <1% 775 $18K
84305 <1% 1,099 $18K
90734 <1% 2,630 $18K
84403 <1% 1,775 $17K
82670 <1% 1,055 $17K
87186 <1% 7,303 $17K
83525 <1% 727 $17K
D2140 <1% 30 $17K
83002 <1% 1,536 $17K
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg <1% 2,324 $17K
82248 <1% 3,956 $17K
86480 <1% 716 $16K
85397 <1% 666 $16K
91318 <1% 1,383 $16K
82607 <1% 1,059 $16K
86317 <1% 1,636 $16K
83021 <1% 1,221 $16K
82272 <1% 1,746 $16K
80164 <1% 744 $15K
95079 <1% 122 $15K
82962 <1% 6,233 $15K
74183 <1% 58 $15K
82247 <1% 3,473 $15K
86580 <1% 779 $14K
90381 <1% 1,816 $14K
85246 <1% 752 $14K
83690 <1% 5,209 $14K
92134 <1% 396 $14K
86376 <1% 1,035 $14K
D2335 <1% 13 $14K
80074 <1% 760 $14K
94760 <1% 31,968 $14K
85240 <1% 712 $14K
82627 <1% 798 $14K
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 8,819 $14K
90380 <1% 1,903 $14K
77074 <1% 1,228 $14K
99157 <1% 424 $14K
87070 <1% 3,955 $14K
70480 <1% 54 $13K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 9,114 $13K
84146 <1% 827 $13K
73080 <1% 1,818 $13K
92015 Determination of refractive state <1% 1,141 $13K
86256 <1% 913 $13K
92541 <1% 184 $13K
82570 <1% 2,112 $13K
72170 <1% 929 $13K
86803 <1% 615 $12K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,278 $12K
70543 <1% 18 $12K
84100 <1% 3,571 $12K
83498 <1% 882 $12K
87328 <1% 787 $12K
97032 <1% 194 $12K
72100 <1% 923 $12K
82785 <1% 1,401 $12K
72040 <1% 868 $12K
36416 <1% 82,791 $12K
92558 <1% 198 $11K
73030 <1% 1,181 $11K
96118 <1% 116 $11K
73100 <1% 1,413 $11K
82550 <1% 1,676 $11K
82024 <1% 326 $11K
73564 <1% 1,150 $11K
76010 <1% 922 $11K
93320 <1% 3,929 $11K
87045 <1% 891 $11K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 757 $11K
86920 <1% 331 $11K
85651 <1% 4,618 $10K
87046 <1% 926 $10K
95816 <1% 30 $10K
87329 <1% 784 $10K
J2704 Injection, propofol, 10 mg <1% 41,507 $10K
D4342 <1% 18 $10K
90713 <1% 1,820 $10K
0479T <1% 27 $10K
86038 <1% 662 $10K
86308 <1% 2,290 $10K
92201 <1% 166 $9K
93321 <1% 2,897 $9K
87899 <1% 1,539 $9K
86901 <1% 1,542 $9K
92542 <1% 184 $9K
90473 <1% 483 $9K
12002 <1% 30 $9K
85046 <1% 4,034 $9K
71045 Radiologic examination, chest; single view <1% 1,000 $9K
84510 <1% 394 $8K
81479 Unlisted molecular pathology procedure <1% 762 $8K
77076 <1% 605 $8K
J7121 5% dextrose in lactated ringers infusion, up to 1000 cc <1% 1,340 $8K
84480 <1% 747 $8K
40806 <1% 71 $8K
96131 <1% 105 $8K
87040 <1% 2,575 $8K
83615 <1% 2,299 $8K
84030 <1% 423 $8K
87529 <1% 986 $8K
72072 <1% 512 $8K
J7030 Infusion, normal saline solution , 1000 cc <1% 25,728 $7K
86800 <1% 778 $7K
94664 <1% 5,733 $7K
73000 <1% 844 $7K
73552 <1% 709 $7K
82157 <1% 360 $7K
D1120 Dental cleaning, child <1% 1,760 $7K
92522 <1% 62 $7K
85730 <1% 2,570 $7K
86355 <1% 484 $6K
84270 <1% 696 $6K
96450 <1% 19 $6K
73070 <1% 754 $6K
84402 <1% 798 $6K
82945 <1% 800 $6K
90461 <1% 18,827 $6K
0074A <1% 229 $6K
00300 <1% 1,001 $6K
91321 <1% 650 $6K
74270 <1% 26 $6K
82565 <1% 1,126 $6K
80177 <1% 451 $6K
70544 <1% 14 $6K
82610 <1% 682 $6K
86160 <1% 743 $5K
70250 <1% 368 $5K
82525 <1% 285 $5K
73660 <1% 706 $5K
51701 <1% 2,305 $5K
0051A <1% 203 $5K
51600 <1% 144 $5K
84145 <1% 1,107 $5K
80143 <1% 1,177 $5K
00140 <1% 1,594 $5K
31575 <1% 12 $5K
73560 <1% 544 $5K
86618 <1% 732 $5K
L8699 Prosthetic implant, not otherwise specified <1% 65 $5K
90672 <1% 478 $5K
86359 <1% 528 $5K
86664 <1% 434 $5K
73060 <1% 524 $5K
87205 <1% 2,753 $5K
90792 Psychiatric diagnostic evaluation with medical services <1% 14 $5K
51728 <1% 18 $5K
0052A <1% 119 $4K
84450 <1% 611 $4K
96120 <1% 20 $4K
J7120 Ringers lactate infusion, up to 1000 cc <1% 39,687 $4K
86706 <1% 445 $4K
0173A <1% 272 $4K
92626 <1% 32 $4K
82043 <1% 1,233 $4K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 59,046 $4K
86360 <1% 484 $4K
86357 <1% 486 $4K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 210 $4K
84156 <1% 938 $4K
87338 <1% 193 $4K
84550 <1% 946 $4K
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 10,561 $4K
82330 <1% 1,570 $3K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 6,409 $3K
87808 <1% 592 $3K
84703 <1% 1,139 $3K
76830 Ultrasound, transvaginal <1% 295 $3K
87340 <1% 215 $3K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,381 $3K
91322 <1% 310 $3K
82746 <1% 414 $3K
76942 <1% 908 $3K
97163 <1% 31 $3K
84484 <1% 569 $3K
97156 <1% 26 $3K
87497 <1% 110 $3K
00126 <1% 3,414 $3K
82077 <1% 962 $3K
96119 <1% 45 $3K
87088 <1% 973 $3K
92083 <1% 39 $3K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 786 $3K
51797 <1% 17 $3K
72146 <1% 68 $3K
80339 <1% 98 $3K
72020 <1% 213 $3K
72125 Computed tomography, cervical spine; without contrast material <1% 26 $3K
36591 <1% 422 $3K
D0272 Bitewings - two radiographic images <1% 4,037 $3K
0083A <1% 143 $3K
51741 <1% 55 $2K
80183 <1% 126 $2K
87799 <1% 391 $2K
88341 <1% 14 $2K
00920 <1% 806 $2K
84134 <1% 231 $2K
83605 <1% 1,237 $2K
V5266 Battery for use in hearing device <1% 577 $2K
86341 <1% 158 $2K
82948 <1% 849 $2K
J8540 Dexamethasone, oral, 0.25 mg <1% 5,085 $2K
94726 <1% 32 $2K
87634 <1% 1,034 $2K
J1815 Injection, insulin, per 5 units <1% 162 $2K
86008 <1% 293 $2K
82803 <1% 1,380 $2K
96133 <1% 155 $2K
80179 <1% 1,052 $2K
29355 <1% 12 $2K
87522 Neg quan hep c or qual rna <1% 104 $2K
96381 <1% 111 $2K
88300 <1% 5,357 $2K
97018 <1% 37 $2K
82105 <1% 136 $2K
72110 <1% 55 $2K
00731 <1% 1,389 $2K
86225 <1% 231 $2K
84132 <1% 1,194 $2K
76642 <1% 15 $2K
86663 <1% 169 $2K
V5264 Ear mold/insert, not disposable, any type <1% 58 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 7,743 $2K
82140 <1% 125 $2K
96375 Therapeutic injection; each additional sequential IV push <1% 5,600 $2K
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 7,074 $2K
84445 <1% 61 $2K
84520 <1% 952 $2K
71110 <1% 113 $2K
84630 <1% 113 $1K
96150 <1% 13 $1K
96376 <1% 580 $1K
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 1,485 $1K
86060 <1% 67 $1K
84702 <1% 43 $1K
82310 <1% 144 $1K
76376 <1% 2,575 $1K
80349 <1% 240 $1K
86617 <1% 155 $1K
86611 <1% 90 $1K
83880 <1% 174 $1K
82150 <1% 177 $1K
J0736 Injection, clindamycin phosphate, 300 mg <1% 576 $1K
88304 <1% 1,259 $1K
64644 <1% 16 $1K
95713 <1% 13 $1K
94761 <1% 48,035 $1K
85576 <1% 38 $1K
87536 <1% 53 $1K
70310 <1% 4,729 $1K
J7042 5% dextrose/normal saline (500 ml = 1 unit) <1% 1,324 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 36,254 $1K
81374 <1% 26 $1K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 810 $1K
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 1,095 $982.73
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 64,989 $961.54
81003 <1% 293 $960.55
88291 <1% 18 $958.66
87181 <1% 330 $899.23
J0690 Injection, cefazolin sodium, 500 mg <1% 4,615 $891.29
95012 <1% 28 $875.76
84446 <1% 120 $856.46
94667 <1% 16 $856.18
84295 <1% 240 $842.12
87807 <1% 1,468 $836.88
85014 <1% 252 $831.66
84681 <1% 91 $830.70
88342 <1% 583 $826.52
93971 <1% 15 $807.95
90660 <1% 77 $783.96
J3010 Injection, fentanyl citrate, 0.1 mg <1% 29,979 $778.81
96380 <1% 2,376 $771.36
80305 <1% 1,181 $763.21
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 255 $736.31
84590 <1% 113 $715.58
93270 <1% 15 $703.92
87075 <1% 385 $682.00
82010 <1% 58 $677.88
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 3,436 $634.64
80175 <1% 27 $604.97
82435 <1% 807 $604.21
82085 <1% 42 $594.46
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 9,339 $592.22
86645 <1% 46 $584.04
J0694 Injection, cefoxitin sodium, 1 gm <1% 123 $581.18
96409 <1% 378 $572.07
J7510 Prednisolone oral, per 5 mg <1% 2,059 $555.89
82657 <1% 466 $523.12
82017 <1% 53 $501.93
J1170 Injection, hydromorphone, up to 4 mg <1% 6,493 $490.88
86430 <1% 58 $489.29
84302 <1% 952 $468.43
89051 <1% 285 $465.24
87101 <1% 95 $454.14
95712 <1% 12 $449.29
86644 <1% 37 $437.53
0054A <1% 12 $434.20
72220 <1% 52 $433.18
00813 <1% 859 $427.18
01730 <1% 16 $415.32
01991 <1% 13 $407.41
00635 <1% 63 $407.41
84466 <1% 53 $396.85
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 682 $394.97
00840 <1% 643 $391.38
81005 <1% 361 $372.14
93271 <1% 15 $351.92
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 1,377 $347.34
86337 <1% 28 $330.91
87102 <1% 152 $319.55
83630 <1% 13 $303.25
82951 <1% 13 $298.82
95018 <1% 54 $291.19
J1953 Injection, levetiracetam, 10 mg <1% 60 $275.22
85379 <1% 123 $270.94
90840 <1% 988 $251.78
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 82 $248.39
84075 <1% 65 $228.96
86235 <1% 30 $220.31
73600 <1% 13 $202.62
J9370 Vincristine sulfate, 1 mg <1% 348 $198.74
85384 <1% 58 $191.09
86774 <1% 33 $186.34
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,795 $182.85
84207 <1% 19 $178.84
J0692 Injection, cefepime hydrochloride, 500 mg <1% 331 $177.99
86735 <1% 36 $163.80
99174 <1% 73 $157.01
90732 <1% 15 $140.60
J0780 Injection, prochlorperazine, up to 10 mg <1% 528 $138.02
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 3,437 $132.36
83986 <1% 21 $129.49
29125 <1% 70 $127.72
82465 <1% 14 $122.62
C1769 Guide wire <1% 473 $122.43
84155 <1% 19 $110.87
85044 <1% 49 $109.80
86762 <1% 17 $84.44
A4467 Belt, strap, sleeve, garment, or covering, any type <1% 17 $83.20
J1580 Injection, garamycin, gentamicin, up to 80 mg <1% 643 $82.36
80230 <1% 79 $80.98
86787 <1% 12 $65.31
87581 <1% 19 $62.57
J2060 Injection, lorazepam, 2 mg <1% 248 $56.27
91307 <1% 5,011 $48.31
84157 <1% 104 $46.03
J3475 Injection, magnesium sulfate, per 500 mg <1% 398 $41.70
91308 <1% 3,105 $28.39
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 180 $26.53
J7060 5% dextrose/water (500 ml = 1 unit) <1% 113 $25.24
81050 <1% 68 $24.58
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 677 $23.98
86039 <1% 12 $23.67
91300 <1% 2,115 $20.38
91315 <1% 1,612 $14.73
91312 <1% 1,561 $14.36
91305 <1% 611 $5.79
J1171 Injection, hydromorphone, 0.1 mg <1% 370 $3.79
91317 <1% 458 $2.50
92608 0% 55 $0.00
87116 0% 28 $0.00
01400 0% 67 $0.00
87206 0% 28 $0.00
00752 0% 36 $0.00
J1030 Injection, methylprednisolone acetate, 40 mg 0% 19 $0.00
C1763 Connective tissue, non-human (includes synthetic) 0% 32 $0.00
01480 0% 17 $0.00
29130 0% 27 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 18 $0.00
95873 0% 152 $0.00
95874 0% 237 $0.00
96159 0% 480 $0.00
01830 0% 32 $0.00
01470 0% 12 $0.00
01810 0% 12 $0.00
96402 0% 14 $0.00
69210 0% 12 $0.00
J9260 Injection, methotrexate sodium, 50 mg 0% 15 $0.00
29105 0% 13 $0.00
01820 0% 22 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLAMANCUSA, ALICIA (DIRECTOR FINANCE)
Same official

Other billing entities under LAMANCUSA, ALICIA

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.